Avigen, Lawrence Berkeley Laboratory deal

AVGN obtained an exclusive worldwide license to the laboratory's interest in a patent covering AVGN's adeno-associated virus vector to deliver a gene to treat Parkinson's disease (PD). AVGN also will ...